Search
Timolol
go.drugbank.com/drugs/DB00373ApprovedInvestigational[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978. … [L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.
Mixtures: LATANOPROST CO 50UG/ML+5MG, LATANOPROST CO 50UG/ML+5MGCategories: Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and ThiazidesDextromethorphan
go.drugbank.com/drugs/DB00514ApprovedInvestigational[A215412] Although similar in structure to other opioids, it has minimal interaction with opioid receptors.[A215412] Dextromethorphan was granted FDA approval before 3 December 1957.
Mixtures: N - Time, G-Tuss-NLCategories: Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeNizatidine
go.drugbank.com/drugs/DB00585ApprovedA histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.
Categories: Hepatotoxic Agents, Less DILI ConcernSynonyms: N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamineSodium chloride
go.drugbank.com/drugs/DB09153ApprovedInvestigationalVet approvedIt is listed on the World Health Organization Model List of Essential Medicines.
Mixtures: Dextrose and Electrolyte No. 75, SOLUCION RINGER NO.3Products: SUERO FISIOLÓGICO NO ESTÉRIL, Na-zoneFexofenadine
go.drugbank.com/drugs/DB00950ApprovedInvestigational[L4269] It is selective for the H<sub>1</sub> receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation … antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.
Categories: Histamine H1 Antagonists, Non-SedatingProducts: FEXODINA® NF 30 MG / 5 ML SUSPENSIÓN ORAL, Allergy Relief non-drowsyMineral oil
go.drugbank.com/drugs/DB11057ApprovedInvestigationalVet approvedPetroleum mineral oil is manufactured from crude oils by vacuum distillation to produce several distillates and a residual oil that are then further refined. … Mineral oil, or paraffin oil, is a mixture of higher alkanes from a mineral source, such as petroleum.
Products: Mizon No.1 Kingsberry Cleansing Oi L, Enema Mineral Oil Ready To UseHydromorphone
go.drugbank.com/drugs/DB00327ApprovedIllicitInvestigationalStructurally, hydromorphone derived from [morphine] in the modification of the hydroxyl group in the carbon 6 to a carbonyl and the absence of a double bond between the carbon 7 and 8. … [A176495] The first reported approved product containing hydromorphone in the form of hydromorphone hydrochloride was developed by Fresenius Kabi USA and FDA approved in 1984.[L5795]
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: HYDROMORPHON-NX 1XTGL 4MG, HYDROMORPHON-NX 1XTGL 8MGIndapamide
go.drugbank.com/drugs/DB00808ApprovedInvestigationalhypertension should include a number of lifestyle changes (ie. reduced sodium intake) along with pharmacotherapy - it should be noted that treatment with several antihypertensive agents may be required in order … [A204155] Characterized by an office blood pressure of ≥140/90, hypertension is pervasive and impacts an estimated 25% of adults globally.
Mixtures: BIPRETERAX N 5MG/1.25MG, BIPRETERAX N 5MG/1.25MGCategories: Non Potassium Sparing DiureticsNitazoxanide
go.drugbank.com/drugs/DB00507ApprovedInvestigationalVet approvedNitazoxanide is a first-line, standard treatment for illness caused by C. parvum or G. lamblia infection in healthy (not immunosuppressed) adults and children and may also be considered in the treatment … of illnesses caused by other protozoa or helminths [A31976].
Products: N/a, KAINOL® NFGlyburide
go.drugbank.com/drugs/DB01016ApprovedInvestigational[A183617] Glyburide was granted FDA approval on 1 May 1984.[L8117] A formulation with metformin was granted FDA approval on on 31 July 2000.[L8120] … Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II.
Categories: Hepatotoxic Agents, Less DILI ConcernSynonyms: 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide, 1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea